Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Carrier Screening is a Deficient Strategy for Determining Sperm Donor Eligibility and Reducing Risk of Disease in Recipient Children.

Silver AJ, Larson JL, Silver MJ, Lim RM, Borroto C, Spurrier B, Morriss A, Silver LM.

Genet Test Mol Biomarkers. 2016 Jun;20(6):276-84. doi: 10.1089/gtmb.2016.0014. Epub 2016 Apr 22.

2.

Response to Sosnay et al.

Larson JL, Lim RM, Silver AJ, Silver MJ, Borroto C, Spurrier B, Petrossian TC, Silver LM.

Genet Med. 2016 Feb;18(2):209-10. doi: 10.1038/gim.2015.106. Epub 2015 Oct 29. No abstract available.

PMID:
26513348
3.

Validation of a high resolution NGS method for detecting spinal muscular atrophy carriers among phase 3 participants in the 1000 Genomes Project.

Larson JL, Silver AJ, Chan D, Borroto C, Spurrier B, Silver LM.

BMC Med Genet. 2015 Oct 29;16:100. doi: 10.1186/s12881-015-0246-2.

4.

Targeted mutation screening panels expose systematic population bias in detection of cystic fibrosis risk.

Lim RM, Silver AJ, Silver MJ, Borroto C, Spurrier B, Petrossian TC, Larson JL, Silver LM.

Genet Med. 2016 Feb;18(2):174-9. doi: 10.1038/gim.2015.52. Epub 2015 Apr 16.

PMID:
25880441
5.

Structure-based functional characterization of repressor of toxin (Rot), a central regulator of Staphylococcus aureus virulence.

Killikelly A, Benson MA, Ohneck EA, Sampson JM, Jakoncic J, Spurrier B, Torres VJ, Kong XP.

J Bacteriol. 2015 Jan 1;197(1):188-200. doi: 10.1128/JB.02317-14. Epub 2014 Oct 20.

6.

Perceptions of video-based appointments from the patient's home: a patient survey.

Gardner MR, Jenkins SM, O'Neil DA, Wood DL, Spurrier BR, Pruthi S.

Telemed J E Health. 2015 Apr;21(4):281-5. doi: 10.1089/tmj.2014.0037. Epub 2014 Aug 28.

7.

Functional implications of the binding mode of a human conformation-dependent V2 monoclonal antibody against HIV.

Spurrier B, Sampson J, Gorny MK, Zolla-Pazner S, Kong XP.

J Virol. 2014 Apr;88(8):4100-12. doi: 10.1128/JVI.03153-13. Epub 2014 Jan 29.

8.

Thermodynamic signatures of the antigen binding site of mAb 447-52D targeting the third variable region of HIV-1 gp120.

Killikelly A, Zhang HT, Spurrier B, Williams C, Gorny MK, Zolla-Pazner S, Kong XP.

Biochemistry. 2013 Sep 10;52(36):6249-57. doi: 10.1021/bi400645e. Epub 2013 Aug 23.

9.

Epitope mapping of conformational V2-specific anti-HIV human monoclonal antibodies reveals an immunodominant site in V2.

Mayr LM, Cohen S, Spurrier B, Kong XP, Zolla-Pazner S.

PLoS One. 2013 Jul 29;8(7):e70859. doi: 10.1371/journal.pone.0070859. Print 2013.

10.

Functional and immunochemical cross-reactivity of V2-specific monoclonal antibodies from HIV-1-infected individuals.

Gorny MK, Pan R, Williams C, Wang XH, Volsky B, O'Neal T, Spurrier B, Sampson JM, Li L, Seaman MS, Kong XP, Zolla-Pazner S.

Virology. 2012 Jun 5;427(2):198-207. doi: 10.1016/j.virol.2012.02.003. Epub 2012 Mar 7.

11.

Health reform: a community experience using design research as a guide.

Severson MA, Wood DL, Chastain CN, Lee LG, Rees AC, Agerter DC, Holtz CP, Broers JK, Savoleinen KH, Spurrier BR, Larusso NF.

Mayo Clin Proc. 2011 Oct;86(10):973-80. doi: 10.4065/mcp.2011.0225.

12.

Structural analysis of human and macaque mAbs 2909 and 2.5B: implications for the configuration of the quaternary neutralizing epitope of HIV-1 gp120.

Spurrier B, Sampson JM, Totrov M, Li H, O'Neal T, Williams C, Robinson J, Gorny MK, Zolla-Pazner S, Kong XP.

Structure. 2011 May 11;19(5):691-9. doi: 10.1016/j.str.2011.02.012.

13.

Identification of tumor and invasion suppressor gene modulators in bladder cancer by different classes of histone deacetylase inhibitors using reverse phase protein arrays.

Gould JJ, Kenney PA, Rieger-Christ KM, Silva Neto B, Wszolek MF, LaVoie A, Holway AH, Spurrier B, Austin J, Cammarata BK, Canes D, Libertino JA, Summerhayes IC.

J Urol. 2010 Jun;183(6):2395-402. doi: 10.1016/j.juro.2010.02.004. Epub 2010 Apr 18.

PMID:
20403623
14.

Reverse-phase protein lysate microarrays for cell signaling analysis.

Spurrier B, Ramalingam S, Nishizuka S.

Nat Protoc. 2008;3(11):1796-808. doi: 10.1038/nprot.2008.179.

PMID:
18974738
15.

Standardized care processes to improve quality and safety of patient care in a large academic practice: the Plummer Project of the Department of Medicine, Mayo Clinic.

Wood DL, Brennan MD, Chaudhry R, Chihak AA, Feyereisn WL, Woychick NL, Hagen PT, Curtright JW, Naessens JM, Spurrier BR, Larusso NF.

Health Serv Manage Res. 2008 Nov;21(4):276-80. doi: 10.1258/hsmr.2008.008009.

PMID:
18957404
16.

Protein and lysate array technologies in cancer research.

Spurrier B, Honkanen P, Holway A, Kumamoto K, Terashima M, Takenoshita S, Wakabayashi G, Austin J, Nishizuka S.

Biotechnol Adv. 2008 Jul-Aug;26(4):361-9. doi: 10.1016/j.biotechadv.2008.04.002. Epub 2008 Apr 20. Review.

PMID:
18514460
17.

[Application of quantitative proteomic analysis for cancer therapy using "reverse-phase" protein lysate microarrays].

Nishizuka S, Spurrier B, Honkanen P, Austin J, Wakabayashi G.

Gan To Kagaku Ryoho. 2008 Feb;35(2):200-5. Japanese.

PMID:
18281757
18.

Experimental validation for quantitative protein network models.

Nishizuka S, Spurrier B.

Curr Opin Biotechnol. 2008 Feb;19(1):41-9. doi: 10.1016/j.copbio.2007.11.007. Epub 2008 Jan 9. Review.

PMID:
18187317
19.

Quantitative protein network monitoring in response to DNA damage.

Nishizuka S, Ramalingam S, Spurrier B, Washburn FL, Krishna R, Honkanen P, Young L, Tsutomu S, Steeg PS, Austin J.

J Proteome Res. 2008 Feb;7(2):803-8. doi: 10.1021/pr0702971.

PMID:
18173236
20.

Antibody screening database for protein kinetic modeling.

Spurrier B, Washburn FL, Asin S, Ramalingam S, Nishizuka S.

Proteomics. 2007 Sep;7(18):3259-63.

PMID:
17708592
21.
22.

Restructuring the inpatient practice of an academic internal medicine department.

Tangalos EG, Spurrier BR, Wood DL, Locke GR 3rd.

Acad Med. 2000 Oct;75(10):1038-40.

PMID:
11031156

Supplemental Content

Loading ...
Support Center